EQUIVAC 2IN1 VACCINE

País: Austràlia

Idioma: anglès

Font: APVMA (Australian Pesticides and Veterinary Medicines Authority)

ingredients actius:

STREPTOCOCCUS EQUI AS CELL FREE EXTRACT; CLOSTRIDIUM TETANI UF TOXOID; THIOMERSAL

Disponible des:

ZOETIS AUSTRALIA PTY LTD

Designació comuna internacional (DCI):

Cl tetani - toxoid(20Lf/mL)+vaccine - strangles(250ul/mL)

formulario farmacéutico:

MISC. VACCINES OR ANTI SERA

Composición:

STREPTOCOCCUS EQUI AS CELL FREE EXTRACT VACCINE-MICROBIAL Active 0.0 P; CLOSTRIDIUM TETANI UF TOXOID VACCINE-TOXOID Active 0.0 P; THIOMERSAL MERCURY Other 0.1 mg/ml

Unidades en paquete:

1 x 1mL; 1mL

clase:

VM - Veterinary Medicine

Fabricat per:

ZOETIS AUSTRALIA

Grupo terapéutico:

HORSE | COLT | DONKEY | ENDURANCE HORSE | FILLY | FOAL | GELDING | HIGH PERFORMANCE HORSES | HORSES AT STUD | MARE | PACER | POL

Área terapéutica:

IMMUNOTHERAPY

indicaciones terapéuticas:

STRANGLES | TETANUS | TETANUS VACCINATION

Resumen del producto:

Poison schedule: 0; Withholding period: WHP: MEAT: Nil.; Host/pest details: HORSE: [STRANGLES, TETANUS]; Poison schedule: 0; Withholding period: ; Host/pest details: HORSE: [STRANGLES, TETANUS]; For the immunisation of horses against tetanus, and strangles caused by Streptococcus equi.

Estat d'Autorització:

Registered

Data d'autorització:

2023-07-01

Informació per a l'usuari

AUSTRALIAN GOVERNMENT
AUSTRALIAN PESTICIDES AND
VETERINARY MEDICINES AUTHORITY
APPENDIX 2
TEMPLATE FOR RELEVANT LABEL PARTICULARS (RLPS)
(VETERINARY PRODUCTS)
Select appropriate:
0
New Product (include all applicable RLPs) OR
El Variation (highlight instructions that are being varied). Approval
no. of label being varied: 51773/1006.
Signal
heading:
FOR ANIMAL TREATMENT ONLY
Product name:
EQUIVAC® 2INL VACCINE
Active constituent/s:
Equivac 24
.11
is a purified
adjuvanted vaccine containing the formalinized
toxin
of
Clostridium tetani
20 Lf/mL and a sterile, cell-free extract of
Streptococcus equi
250pL/mL. The adjuvant, which is an aluminium salt, increases the
level and duration of
the immunity afforded by the vaccine. The product contains no living
organisms.
Thiomersal 0.1 mg/mL is added as a preservative.
Statement of claims:
For the immunisation of horses against tetanus, and strangles caused
by
Streptococcus
equi.
Net contents:
1mL
dose syringe.
Directions for Use
Heading:
RLP
Approved
READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT
DIRECTIONS FOR USE
Contents must be left in outer package until immediately before use
Shake well before use.
There may be settling of the adjuvant after storage but material is
easily resuspended by
inversion of the syringe.
Before the vaccine is injected, the proposed site of inoculation on
the horses skin may be
cleaned by swabbing with cotton-wool soaked in a suitable antiseptic
solution, such as
methylated spirits.
Restraints:
N/A
Contraindications:
N/A
Precautions:
N/A
Side effects:
Localised swelling may occasionally develop at the site of injection.
On rare occasions
systemic signs have been observed following vaccination against
strangles. This appears
to occur when horses have been sensitized to
Streptococcus equi
by exposure to
infection or when they are incubating the disease. Horses which show
an abnormally
severe reaction following vaccination should not receive further doses
of vaccine
containing a strangles component for twelve months. Tetanus
immunisation sh

Fitxa tècnica

PRODUCT NAME: EQUIVAC
® 2 IN 1 VACCINE
PAGE: 1 OF 5
THIS REVISION ISSUED: JUNE, 2010
MATERIAL SAFETY DATA SHEET
Issued by: Pfizer Australia Pty Ltd
Phone: [phone]
SECTION 1 - IDENTIFICATION OF THE MATERIAL AND SUPPLIER
Pfizer Australia Pty Ltd
38-42 Wharf Road
West Ryde NSW 2114
Tel: [phone]
Fax: [phone]
____________________________________
PFIZER AUSTRALIA PTY LTD
A.B.N. 50 008 422 348
CHEMICAL NATURE:
Saline suspension of vaccine ingredients.
TRADE NAME:
EQUIVAC
® 2 IN 1 VACCINE
PFIZER MSDS CODE:
0991
PRODUCT USE:
Vaccine for the prevention of tetanus and strangles in horses.
CREATION DATE:
AUGUST, 2004
THIS VERSION ISSUED:
JUNE, 2010
and is valid for 5 years from this date.
SECTION 2 - HAZARDS IDENTIFICATION
STATEMENT OF HAZARDOUS NATURE
This product is classified as:
Not classified as hazardous according to the criteria of SWA
Australia.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
Not Hazardous - No criteria found.
SAFETY PHRASES:
Not Hazardous - No criteria found.
SUSDP CLASSIFICATION:
None allocated. (NZ S2)
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good.
UN NUMBER:
None allocated
E
E
E
M
M
M
E
E
E
R
R
R
G
G
G
E
E
E
N
N
N
C
C
C
Y
Y
Y
O
O
O
V
V
V
E
E
E
R
R
R
V
V
V
I
I
I
E
E
E
W
W
W
PHYSICAL DESCRIPTION & COLOUR
: Aqueous liquid suspension.
ODOUR:
No odour.
MAJOR HEALTH HAZARDS:
no significant risk factors have been found for this product.
P
P
P
O
O
O
T
T
T
E
E
E
N
N
N
T
T
T
I
I
I
A
A
A
L
L
L
H
H
H
E
E
E
A
A
A
L
L
L
T
T
T
H
H
H
E
E
E
F
F
F
F
F
F
E
E
E
C
C
C
T
T
T
S
S
S
INHALATION
SHORT TERM EXPOSURE:
Significant inhalation exposure is considered to be unlikely.
Available data indicates that this
product is not harmful. In addition product is unlikely to cause any
discomfort or irritation.
LONG TERM EXPOSURE:
No data for health effects associated with long term inhalation.
SKIN CONTACT:
SHORT TERM EXPOSURE:
Available data indicates that this product is not harmful. It should
present no hazards in
normal use. However product may be m